Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Characterisation of a novel gr...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Characterisation of a novel group B oncolytic adenovirus, ColoAd1
Show other versions (1)
Bibliographic Details
Main Authors:
Di, Y
,
Illingworth, S
,
Roesen, N
,
Fisher, K
,
Seymour, L
Format:
Journal article
Published:
2011
Holdings
Description
Other Versions (1)
Similar Items
Staff View
Similar Items
Characterisation of a novel group B oncolytic adenovirus, ColoAd1
by: Di, Y
Published: (2011)
Arming ColoAd1 with tumor necrosis factor alpha and lymphotoxin alpha
by: Koelen, J
Published: (2015)
Preclinical safety studies of enadenotucirev, a chimeric group B human-specific oncolytic adenovirus
by: Illingworth, S, et al.
Published: (2017)
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
by: Sam Illingworth, et al.
Published: (2017-06-01)
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
by: Dyer, A, et al.
Published: (2016)